PapersFlow Research Brief
Obstructive Sleep Apnea Research
Research Guide
What is Obstructive Sleep Apnea Research?
Obstructive Sleep Apnea Research is the scientific investigation into the causes, prevalence, diagnosis, measurement standards, and health consequences of obstructive sleep apnea, a sleep disorder characterized by recurrent upper airway obstruction during sleep.
Obstructive Sleep Apnea Research encompasses over 109,766 published works focused on epidemiology, diagnostic tools, and clinical outcomes. Key contributions include the Epworth Sleepiness Scale for measuring daytime sleepiness, introduced by Murray W. Johns (1991), and standardized scoring rules for respiratory events from the American Academy of Sleep Medicine. Population studies, such as those by Terry Young et al. (1993), established high prevalence rates of sleep-disordered breathing among middle-aged adults.
Research Sub-Topics
Polysomnography Scoring Standards
Standardized rules for scoring sleep stages, arousals, and respiratory events from PSG recordings. Researchers validate automated scoring algorithms against AASM manual criteria.
CPAP Treatment Efficacy
Continuous positive airway pressure therapy reduces apnea-hypopnea events and improves symptoms. Researchers conduct RCTs evaluating cardiovascular, neurocognitive, and mortality outcomes.
Cardiovascular Consequences
OSA independently increases hypertension, arrhythmia, and cardiovascular event risk. Researchers elucidate intermittent hypoxia mechanisms and CPAP's blood pressure effects.
Epidemiological Prevalence Studies
Population-based studies determine OSA prevalence using validated questionnaires and objective testing. Researchers examine demographic trends, risk factors, and global burden estimates.
Epworth Sleepiness Scale Validation
The ESS measures subjective daytime sleepiness in OSA patients and treatment monitoring. Researchers validate ESS against MSLT and evaluate responsiveness to therapy.
Why It Matters
Obstructive Sleep Apnea Research identifies risks like hypertension and cardiovascular disease, informing treatments such as continuous positive airway pressure (CPAP). Paul E. Peppard et al. (2000) demonstrated a dose-response association between sleep-disordered breathing and hypertension four years later, independent of confounders, affecting millions globally. José M. Marın et al. (2005) showed untreated obstructive sleep apnoea-hypopnoea increased long-term cardiovascular mortality in men, reduced by CPAP. Recent developments include a sleep apnea pill trial with 646 participants by Apnimed and an $80 million financing for Mosanna Therapeutics' nasal spray, alongside UCSD trials exploring CPAP, eszopiclone, and oxygen responses.
Reading Guide
Where to Start
"Epidemiology of Obstructive Sleep Apnea" by Terry Young, Paul E. Peppard, Daniel J. Gottlieb (2002) provides foundational population-based evidence on prevalence and morbidity, ideal for beginners before diving into diagnostics or outcomes.
Key Papers Explained
Murray W. Johns (1991) introduced the Epworth Sleepiness Scale for daytime sleepiness measurement, foundational for symptom assessment. Terry Young et al. (1993) established prevalence of sleep-disordered breathing, building the epidemiological base cited in Terry Young et al. (2002)'s comprehensive epidemiology review. Paul E. Peppard et al. (2000) linked this to hypertension risks, while José M. Marın et al. (2005) extended to cardiovascular outcomes with CPAP effects, connecting symptoms to long-term health impacts.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints explore integrated sensor systems for home PSG alternatives and PPG-based detection via ApSense on GitHub. News highlights Apnimed's pill trial in 646 patients, Mosanna's nasal spray with $80M funding, and Mount Sinai's $3.32M AI grant. UCSD trials test CPAP versus eszopiclone/oxygen, and studies link untreated OSA to Parkinson's risk.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | A New Method for Measuring Daytime Sleepiness: The Epworth Sle... | 1991 | SLEEP | 16.7K | ✓ |
| 2 | The Occurrence of Sleep-Disordered Breathing among Middle-Aged... | 1993 | New England Journal of... | 10.2K | ✓ |
| 3 | The American Academy of Sleep Medicine (AASM) Manual for the S... | 2007 | — | 6.6K | ✕ |
| 4 | Sleep–Related Breathing Disorders in Adults: Recommendations f... | 1999 | SLEEP | 5.1K | ✕ |
| 5 | Rules for Scoring Respiratory Events in Sleep: Update of the 2... | 2012 | Journal of Clinical Sl... | 5.0K | ✓ |
| 6 | Prospective Study of the Association between Sleep-Disordered ... | 2000 | New England Journal of... | 4.9K | ✓ |
| 7 | Long-term cardiovascular outcomes in men with obstructive slee... | 2005 | The Lancet | 4.6K | ✕ |
| 8 | Increased Prevalence of Sleep-Disordered Breathing in Adults | 2013 | American Journal of Ep... | 4.5K | ✓ |
| 9 | Epidemiology of Obstructive Sleep Apnea | 2002 | American Journal of Re... | 4.2K | ✕ |
| 10 | Estimation of the global prevalence and burden of obstructive ... | 2019 | The Lancet Respiratory... | 3.7K | ✓ |
In the News
Sleep Revolution - evaluation of a novel diagnostic and therapeutic pathway for patients with obstructive sleep apnea
A randomized cross over trial exploring the Sleep Revolution diagnostic and therapeutic pathway in patients with obstructive sleep apnea Acronym Sleep Revolution WP 8 study Study objectives
Respiratory effort burden measured by mandibular jaw movements as a digital marker with clinical insights in obstructive sleep apnea
* Published:12 January 2026# Respiratory effort burden measured by mandibular jaw movements as a digital marker with clinical insights in obstructive sleep apnea
Sleep apnea pill shows striking success in large clinical trial
A company called Apnimed was launched in 2017 to commercialize the discovery. After promising results in an early trial, the company launched a larger one in 2023, in which 646 people with OSA were...
Forbion co-leads $80 Million Series A Financing
* Insights * Events * Media resources #### News # Forbion co-leads $80 Million Series A Financing in Mosanna Therapeutics to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea June ...
Mount Sinai Receives $3.32 Million Grant to Study New ...
The Icahn School of Medicine at Mount Sinai has been awarded a $3.32 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to study a...
Code & Tools
ApSense is a novel deep learning approach for detecting Obstructive Sleep Apnea (OSA) events using fingertip Photoplethysmography (PPG) signals. Th...
This repository describes an end-to-end pipeline for using latent class analysis (LCA) for identification of subtypes of obstructive sleep apnea (O...
``` A Screening solution for Obstructive Sleep Apnea that also helps us to monitor the severity of the disease using ML and mobile application. Pre...
## General Information The code in this repository is companion to the paper:
Recent Preprints
Advancing Obstructive Sleep Apnea Management
. 2025 Oct 26;14(21):7586. doi: 10.3390/jcm14217586 # Advancing Obstructive Sleep Apnea Management: Recent Trends from Conventional to Innovative Therapies Soo Kyoung Park ### Soo Kyoung Park
Obstructive Sleep Apnoea Treatments—Where Are We Now?
Obstructive sleep apnoea (OSA) affects up to 1 billion adults worldwide [ 1 ]. The impact of untreated OSA is well described, contributing to an elevated risk of cardiovascular disease, neurocognit...
Untreated sleep apnea raises risk of Parkinson's, study finds
New research reveals that people with untreated obstructive sleep apnea have a higher risk of developing Parkinson’s disease. However, they can significantly reduce the risk by improving the qualit...
UCSD Sleep Apnea Clinical Trials for 2026 — San Diego
This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and respo...
Clinical study of an integrated sensor system for detection ...
Obstructive Sleep Apnea (OSA) is traditionally diagnosed via Polysomnography (PSG), which relies on multiple wired sensors in an unfamiliar hospital setting. In this study, a compact home-sleep-tes...
Latest Developments
Recent developments in obstructive sleep apnea (OSA) research include the approval of the first medication, Zepbound (tirzepatide), in December 2024 for treating moderate to severe OSA in obese patients, which has shown promising results in reducing breathing disruptions (NEJM, Science, published in 2025). Additionally, innovative therapies such as hypoglossal nerve stimulation, anti-obesity pharmacotherapy, and neuromodulation techniques are being actively researched, with recent studies emphasizing precision medicine approaches (PMC, 2025).
Sources
Frequently Asked Questions
What is the Epworth Sleepiness Scale?
The Epworth Sleepiness Scale (ESS) is a self-administered questionnaire developed by Murray W. Johns (1991) to measure general daytime sleepiness in adults. One hundred and eighty adults, including 30 normals, completed it, demonstrating its utility in assessing sleepiness levels. "A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale" (1991) validated its simplicity and effectiveness.
How prevalent is sleep-disordered breathing?
Terry Young et al. (1993) found high prevalence of undiagnosed sleep-disordered breathing among middle-aged men and higher than expected in women, associated with daytime hypersomnolence. P. E. Peppard et al. (2013) updated estimates due to obesity trends, confirming increased prevalence. "The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults" (1993) reported rates much higher than previously suspected.
What are the standards for scoring sleep apnea events?
The AASM Manual by Conrad Iber et al. (2007) provides rules, terminology, and specifications for scoring sleep and associated events. Richard B. Berry et al. (2012) updated these rules for respiratory events in sleep. "Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events" (2012) refined clinical research techniques.
How does sleep apnea relate to hypertension?
Paul E. Peppard et al. (2000) identified a dose-response link between baseline sleep-disordered breathing and hypertension four years later, independent of confounders. This positions sleep-disordered breathing as a risk factor for hypertension. "Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension" (2000) supports targeted interventions.
What is the global burden of obstructive sleep apnea?
Adam Benjafield et al. (2019) estimated global prevalence and burden through literature analysis. Terry Young et al. (2002) detailed epidemiology, noting high undiagnosed rates and morbidity even in mild cases. "Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis" (2019) quantifies impacts worldwide.
Open Research Questions
- ? How do novel therapies like oral pills and nasal sprays compare to CPAP in reducing cardiovascular risks?
- ? Can AI-based tools and wearable sensors accurately diagnose OSA outside polysomnography settings?
- ? What subtypes of OSA symptoms exist, and how do they influence treatment responses?
- ? Does treating OSA with CPAP lower Parkinson's disease risk, and what mechanisms are involved?
- ? How does respiratory effort burden from mandibular movements predict OSA severity?
Recent Trends
Preprints from the last six months emphasize shifts from CPAP to pills, nasal sprays, and home sensors, including Soo Kyoung Park's review of innovative therapies and ApSense's PPG algorithm.
News reports Apnimed's successful trial in 646 OSA patients, $80M for Mosanna Therapeutics' spray, and UCSD 2026 trials on therapy responses.
A 2025 study found untreated OSA raises Parkinson's risk, mitigated by CPAP.
Research Obstructive Sleep Apnea Research with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Obstructive Sleep Apnea Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.